599 related articles for article (PubMed ID: 31823961)
21. The pan-cancer analysis of the two types of uterine cancer uncovered clinical and prognostic associations with m6A RNA methylation regulators.
Zou Z; Zhou S; Liang G; Tang Z; Li K; Tan S; Zhang X; Zhu X
Mol Omics; 2021 Jun; 17(3):438-453. PubMed ID: 34110327
[TBL] [Abstract][Full Text] [Related]
22. m6A Regulators Is Differently Expressed and Correlated With Immune Response of Esophageal Cancer.
Zhao H; Xu Y; Xie Y; Zhang L; Gao M; Li S; Wang F
Front Cell Dev Biol; 2021; 9():650023. PubMed ID: 33748145
[TBL] [Abstract][Full Text] [Related]
23. m6A RNA methylation regulators play an important role in the prognosis of patients with testicular germ cell tumor.
Cong R; Ji C; Zhang J; Zhang Q; Zhou X; Yao L; Luan J; Meng X; Song N
Transl Androl Urol; 2021 Feb; 10(2):662-679. PubMed ID: 33718069
[TBL] [Abstract][Full Text] [Related]
24. Construction and Validation of an m6A RNA Methylation Regulators-Based Prognostic Signature for Esophageal Cancer.
Xu LC; Pan JX; Pan HD
Cancer Manag Res; 2020; 12():5385-5394. PubMed ID: 32753956
[TBL] [Abstract][Full Text] [Related]
25. Identification of an eight-m6A RNA methylation regulator prognostic signature of uterine corpus endometrial carcinoma based on bioinformatics analysis.
Miao C; Fang X; Chen Y; Zhao Y; Guo Q
Medicine (Baltimore); 2021 Dec; 100(49):e27689. PubMed ID: 34889221
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive characterization of tumor microenvironment and m6A RNA methylation regulators and its effects on PD-L1 and immune infiltrates in cervical cancer.
Ji H; Zhang JA; Liu H; Li K; Wang ZW; Zhu X
Front Immunol; 2022; 13():976107. PubMed ID: 36091006
[TBL] [Abstract][Full Text] [Related]
27. Development and Validation of an m6A RNA Methylation Regulator-Based Signature for Prognostic Prediction in Cervical Squamous Cell Carcinoma.
Pan J; Xu L; Pan H
Front Oncol; 2020; 10():1444. PubMed ID: 32974164
[No Abstract] [Full Text] [Related]
28. m
Zhuang J; Lin C; Ye J
J Cell Physiol; 2020 Sep; 235(9):6300-6306. PubMed ID: 32043594
[TBL] [Abstract][Full Text] [Related]
29. Potential role of m6A RNA methylation regulators in osteosarcoma and its clinical prognostic value.
Liu H; Qin G; Ji Y; Wang X; Bao H; Guan X; Wei A; Cai Z
J Orthop Surg Res; 2021 May; 16(1):294. PubMed ID: 33952279
[TBL] [Abstract][Full Text] [Related]
30. m6A regulators are differently expressed and correlated with immune response of pancreatic adenocarcinoma.
Zhang T; Sheng P; Jiang Y
J Cancer Res Clin Oncol; 2023 Jul; 149(7):2805-2822. PubMed ID: 35780396
[TBL] [Abstract][Full Text] [Related]
31. Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma.
Shen C; Liu J; Yang X; Jiao W; Wang Y
Front Endocrinol (Lausanne); 2021; 12():568397. PubMed ID: 33692753
[TBL] [Abstract][Full Text] [Related]
32. Expression pattern and prognostic value of N6-methyladenosine RNA methylation key regulators in hepatocellular carcinoma.
Deng M; Fang L; Li SH; Zhao RC; Mei J; Zou JW; Wei W; Guo RP
Mutagenesis; 2021 Oct; 36(5):369-379. PubMed ID: 34467992
[TBL] [Abstract][Full Text] [Related]
33. N6-Methyladenosine RNA Methylation Regulator-Related Alternative Splicing (AS) Gene Signature Predicts Non-Small Cell Lung Cancer Prognosis.
Zhao Z; Cai Q; Zhang P; He B; Peng X; Tu G; Peng W; Wang L; Yu F; Wang X
Front Mol Biosci; 2021; 8():657087. PubMed ID: 34179079
[TBL] [Abstract][Full Text] [Related]
34. N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma.
Maimaiti A; Tuersunniyazi A; Meng X; Pei Y; Ji W; Feng Z; Jiang L; Wang Z; Kasimu M; Wang Y; Shi X
Front Genet; 2022; 13():872186. PubMed ID: 35937991
[No Abstract] [Full Text] [Related]
35. Comprehensive analysis of m6A regulators prognostic value in prostate cancer.
Ji G; Huang C; He S; Gong Y; Song G; Li X; Zhou L
Aging (Albany NY); 2020 Jul; 12(14):14863-14884. PubMed ID: 32710725
[TBL] [Abstract][Full Text] [Related]
36. Clinical and prognostic pan-cancer analysis of m6A RNA methylation regulators in four types of endocrine system tumors.
Li K; Luo H; Luo H; Zhu X
Aging (Albany NY); 2020 Nov; 12(23):23931-23944. PubMed ID: 33237039
[TBL] [Abstract][Full Text] [Related]
37. Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma.
Qi LW; Jia JH; Jiang CH; Hu JM
Front Genet; 2020; 11():614566. PubMed ID: 33519919
[TBL] [Abstract][Full Text] [Related]
38. Expression and Prognostic Characteristics of m6A RNA Methylation Regulators in Colon Cancer.
Huang L; Zhu J; Kong W; Li P; Zhu S
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670062
[TBL] [Abstract][Full Text] [Related]
39. m6A-Related Genes Contribute to Poor Prognosis of Hepatocellular Carcinoma.
Zou Y; Jiang G; Xie Y; Li H
Comput Math Methods Med; 2022; 2022():2427987. PubMed ID: 36339682
[TBL] [Abstract][Full Text] [Related]
40. Analysis of Genetic Alteration Signatures and Prognostic Values of m6A Regulatory Genes in Head and Neck Squamous Cell Carcinoma.
Zhou X; Han J; Zhen X; Liu Y; Cui Z; Yue Z; Ding L; Xu S
Front Oncol; 2020; 10():718. PubMed ID: 32547941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]